Table 1 |
|||||
| Selection of imaging findings in psychiatric illness | |||||
| Psychiatric illness | Subgroup/genotype | Imaging feature | Sample | Imaging method | Reference |
| Major depressive disorder | • Reduced activity in frontal lobes | Various | PET, fMRI, EEG, SPECT | [351] | |
| • Reduced HPC volumes | Meta-analyses | MRI | [352,353] | ||
| • Greater reduction in HPC volume with increased duration of untreated MDD | 38 male outpatients | MRI | [354] | ||
| • Increased baseline activity in pulvinar nuclei bilaterally | Meta-analysis | PET and SPECT | [343] | ||
| • Increased amygdala, dorsal ACC, and insular response to negative stimuli compared with healthy controls | Meta-analysis | Task-based fMRI | [343] | ||
| • Reduced dlPFC and dorsal striatum response to negative stimuli compared with healthy controls | Meta-analysis | Task-based fMRI | [343] | ||
| 5-HTTLPR -S or Lg allele: | Increased amygdala reactivity to masked emotional faces; correlated to lifetime psychiatric hospitalization in MDD | 35MDD, 32 controls | fMRI | [355] | |
| 5-HTTLPR -S or Lg allele: | Increased bilateral amygdala activation after emotional stimuli (allele effects are additive) | 27 MDD on medication | fMRI | [356] | |
| 5-HT1A - 1019G allele: | |||||
| 5-HTTLPR- L/L: | Reduced HPC volumes compared with controls | 40 MDD, 40 controls | MRI | [357] | |
| Late onset (LO) MDD | 5-HTTLPR- L/L: | Reduced HPC volumes compared with S/L or S/S genotypes | 63 LO MDD, 72 EO MDD, 83 controls | MRI | [358] |
| Early onset (EO) MDD | 5-HTTLPR -S allele: | Reduced HPC volumes compared with left allele carriers | |||
| Bipolar disorder | • Increased size of lateral ventricles (right ventricle only in [359]) | Meta-analyses | CT and MRI | [359-361] | |
| • Increased number of deep white-matter hyperintensities | Meta-analyses | CT and MRI | [360-363] | ||
| • Increased number of subcortical gray-matter hyperintensities | Meta-analysis | MRI | [362] | ||
| • Increased activity in limbic structures (left side only in [364]) | Meta-analyses | fMRI and PET | [364,365] | ||
| • Reduced activity in frontal structures (vlPFC and dlPFC [364]) | |||||
| Pediatric population: | • Reduced amygdala volume | Meta-analyses | MRI | [365,366] | |
| Schizophrenia | • Reduced frontal-lobe activity at rest and during task activation | Meta-analysis | MRI, PET | [367,368] | |
| • Increased lateral ventricular size | Meta-analyses | CT and MRI | [369,370] | ||
| • Increased D2 dopamine receptor density | Meta-analysis | PET and SPECT | [371] | ||
| • Reduced frontal gray matter | Meta-analyses | MRI | [372,373] | ||
| SZ: | • Reduced bilateral HPC volume relative to controls | Meta-analyses | MRI | [374-376] | |
| nonpsychotic 1st deg family: | Meta-analysis | MRI | [370] | ||
| BDNF 66Val/Val carriers: | • Reduced activation of the cingulate, lateral PFC and lateral parietal regions during verbal memory task | 58 high-risk subjects (first-degree or second-degree family with SZ) | fMRI | [377] | |
+/−A, alcohol abuse positive/negative subjects; ACC, anterior cingulate cortex; Cho, choline; CT, computed tomography; DA, dopamine; dlPFC, dorsolateral pre-frontal cortex; EO, early onset; fMRI, functional magnetic resonance imaging; 1H-MRS, proton MR spectroscopy; HPC, hippocampal; LO, late onset; MDD, major depressive disorder; MRI, magnetic resonance imaging; NAA, N-acetylaspartate; parahippocampal gyrus; PET, positron emission tomography; Tx, treated; vlPFC, ventral-lateral pre-frontal cortex; vmPFC, ventral-medial pre-frontal cortex.
Ozomaro et al.
Ozomaro et al. BMC Medicine 2013 11:132 doi:10.1186/1741-7015-11-132